These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The diagnosis of progressive supranuclear palsy: current opinions and challenges. Ali F; Josephs K Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389 [TBL] [Abstract][Full Text] [Related]
10. Thalamic hypoperfusion in early stage of progressive supranuclear palsy (Richardson's syndrome): report of an autopsy-confirmed case. Kobayashi Z; Akaza M; Ishihara S; Tomimitsu H; Inadome Y; Arai T; Akiyama H; Shintani S J Neurol Sci; 2013 Dec; 335(1-2):224-7. PubMed ID: 24075472 [TBL] [Abstract][Full Text] [Related]
11. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome. Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689 [TBL] [Abstract][Full Text] [Related]
12. Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death. Zhang L; Toyoshima Y; Takeshima A; Shimizu H; Tomita I; Onodera O; Takahashi H; Kakita A Neuropathology; 2021 Jun; 41(3):174-182. PubMed ID: 33205528 [TBL] [Abstract][Full Text] [Related]
13. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study. Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450 [TBL] [Abstract][Full Text] [Related]
14. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640 [TBL] [Abstract][Full Text] [Related]
16. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518 [TBL] [Abstract][Full Text] [Related]
17. Progressive supranuclear palsy: what do we know about it? Long L; Cai XD; Wei XB; Liao JC; Xu YQ; Gao HM; Chen XH; Wang Q Curr Med Chem; 2015; 22(10):1182-93. PubMed ID: 25732053 [TBL] [Abstract][Full Text] [Related]
18. Latent trait modeling of tau neuropathology in progressive supranuclear palsy. Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380 [TBL] [Abstract][Full Text] [Related]
19. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Williams DR; Lees AJ Lancet Neurol; 2009 Mar; 8(3):270-9. PubMed ID: 19233037 [TBL] [Abstract][Full Text] [Related]
20. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Boxer AL; Yu JT; Golbe LI; Litvan I; Lang AE; Höglinger GU Lancet Neurol; 2017 Jul; 16(7):552-563. PubMed ID: 28653647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]